What is O2M Technologies?
O2M Technologies specializes in patented oxygen imaging technology, leveraging pulse electron paramagnetic resonance to generate rapid three-dimensional maps of partial oxygen pressure (pO₂) within tissues. Their proprietary JIVA-25 preclinical oxygen imager is designed to enhance clinical diagnostics, refine disease treatment strategies, and accelerate drug development processes. The company targets researchers and professionals in biomedicine, cancer research, and artificial cell replacement technology, also providing contract research services for comprehensive oxygen measurement and project support.
How much funding has O2M Technologies raised?
O2M Technologies has raised a total of $81K across 1 funding round:
Debt
$81K
Debt (2021): $81K with participation from PPP
What's next for O2M Technologies?
With the recent influx of expansion capital, O2M Technologies is poised for significant growth. This strategic investment will likely fuel the scaling of their patented oxygen imaging technology, potentially expanding market reach and accelerating product development cycles. The company's focus on improving diagnostics and drug development positions it to capitalize on the increasing demand for precise biological measurement tools. Future developments may include further technological advancements and broader clinical applications, solidifying their role in cutting-edge biomedical research.
See full O2M Technologies company page
